Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the effect of baricitinib 4-mg once daily (QD) or 2-mg daily QD compared to placebo on remission of SLE arthritis and/or rash in patients with SLE receiving concomitant standard therapy over 24 weeks.
Inclusion criteria
- Patients with Systemic Lupus Erythematosus (SLE)